DENVER, Colo., 18 June, 2024 (247marketnews.com) – (Nasdaq:AEMD) are discussed in this article.
Aethlon Medical Inc. (AEMD) has made notable strides in both its market performance and research advancements. The stock opened at $0.645 and is currently trading at $0.770, reflecting a significant 20.51% increase since the market opened, with a trading volume of 10.4 million shares. Technical analysis points towards a bullish momentum in today’s trading session, indicating potential short-term gains for investors monitoring AEMD’s price movements and trading volumes.
In a significant development for the company, Aethlon Medical has attained full approval from the Human Research Ethics Committee at Central Adelaide Local Health Network for a pivotal study involving its innovative Hemopurifier® technology. This approval represents a crucial step forward in the evaluation of the Hemopurifier®’s safety, feasibility, and optimal dosage in cancer patients with resistant solid tumors, particularly those unresponsive to Anti-PD-1 antibodies.
The Hemopurifier® stands out as a groundbreaking medical device designed to selectively target and eliminate circulating viruses and tumor-secreted exosomes from the bloodstream. By enhancing the body’s immune response, the Hemopurifier® holds immense promise in improving treatment outcomes for patients grappling with challenging solid tumors.
The approval signifies Aethlon Medical’s adherence to stringent scientific and ethical standards, underpinning its commitment to advancing cutting-edge therapies that have the potential to revolutionize cancer treatment. With this pivotal milestone achieved, Aethlon Medical is set to embark on the approved study, bringing it closer to unlocking the full potential of the Hemopurifier® technology in addressing critical medical needs and delivering impactful solutions to patients worldwide.
For further information regarding this significant development, please refer to the official press release available on prnewswire.com.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com